HOUSTON, Dec. 3, 2020 /PRNewswire/ — Eceptionist a world leader in providing healthcare organizations with cloud-based software solutions for referral management, scheduling, and telehealth, announces the release and availability of VaxManager – a SAAS solution specifically designed to help small and large organizations manage the last step of the COVID-19 vaccine distribution to patients and citizens. VaxManager has been designed to alleviate the administrative burden of managing COVID testing, COVID vaccines (when available) and flu shots, all while improving the patient experience with easy-to-use self-service tools. VaxManager offers:
VaxManager is designed to work for small and large private and public health organizations, pharmacies, employers, universities, school districts, churches and any other groups that participate in the distribution of vaccines to patients and citizens. VaxManager service is now available for onboarding.
Eceptionist (www.eceptionist.com) is a leading provider of software solutions for the health care industry with a cloud-based platform for referral management, e-consults, streamlined scheduling, and overall telehealth management. Since 2001, Eceptionist has been helping clients reduce costs and optimize the delivery of healthcare services. Utilizing the Eceptionist family of services, organizations can better manage healthcare delivery across departments, health systems and regions. The Eceptionist platform supports intelligent scheduling, telemedicine, intelligent referrals, triage and wait time management for facilities and hospitals around the world.
All questions and inquiries should be directed to https://eceptionist.com/contact-us/ or 713.520.6688.
View original content:http://www.prnewswire.com/news-releases/eceptionist-announces-the-release-of-vaxmanager-service-301185361.html
SOURCE Eceptionist, Inc.
First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…
New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…
Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…
LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Skirball Cultural Center was…